Feng Shen

1.1k total citations
29 papers, 577 citations indexed

About

Feng Shen is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feng Shen has authored 29 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feng Shen's work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Consumer Behavior in Brand Consumption and Identification (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Feng Shen is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Consumer Behavior in Brand Consumption and Identification (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Feng Shen collaborates with scholars based in China, United States and Hong Kong. Feng Shen's co-authors include Tian Yang, Mengchao Wu, Han Zhang, Jon D. Morris, Lei Xu, Yan Tu, Han Zhang, Shuyang Dai, Yaping Deng and Zhiyong Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Clinical Epidemiology.

In The Last Decade

Feng Shen

25 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Shen China 11 279 147 136 84 83 29 577
Yen‐Hsun Chen Taiwan 13 250 0.9× 24 0.2× 132 1.0× 21 0.3× 51 0.6× 34 808
Mónica López-Santamaría Spain 12 130 0.5× 50 0.3× 188 1.4× 15 0.2× 22 0.3× 40 580
K. Becker United States 14 344 1.2× 133 0.9× 485 3.6× 147 1.8× 30 0.4× 38 892
Meirui Qian China 12 36 0.1× 174 1.2× 101 0.7× 147 1.8× 39 0.5× 20 673
Shuyi Cen China 6 71 0.3× 158 1.1× 73 0.5× 33 0.4× 12 0.1× 8 315
Sang-Chul Park South Korea 11 74 0.3× 95 0.6× 66 0.5× 19 0.2× 21 0.3× 48 431
Dawn Queen United States 11 116 0.4× 65 0.4× 40 0.3× 29 0.3× 75 0.9× 38 546
J. Bogaert Belgium 6 45 0.2× 84 0.6× 65 0.5× 47 0.6× 52 0.6× 17 406
Young-Kyu Park South Korea 11 178 0.6× 60 0.4× 292 2.1× 26 0.3× 5 0.1× 36 773

Countries citing papers authored by Feng Shen

Since Specialization
Citations

This map shows the geographic impact of Feng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Shen more than expected).

Fields of papers citing papers by Feng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Shen. The network helps show where Feng Shen may publish in the future.

Co-authorship network of co-authors of Feng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Shen. A scholar is included among the top collaborators of Feng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Shen. Feng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Zhijie, Junxi Xiang, Matthew J. Weiss, et al.. (2024). Long‐term survivors after curative‐intent resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology. 130(3). 443–452. 3 indexed citations
3.
Chen, Yiwen, Hui‐Chuan Sun, Feng Shen, et al.. (2024). The treatment outcomes of patients who failed to be randomly assigned after atezo/bev induction therapy in the Chinese TALENTop study.. Journal of Clinical Oncology. 42(16_suppl). e16183–e16183. 1 indexed citations
4.
Chen, Zhenfeng, et al.. (2024). Isoliquiritigenin attenuates myocardial ischemia reperfusion through autophagy activation mediated by AMPK/mTOR/ULK1 signaling. BMC Cardiovascular Disorders. 24(1). 415–415. 7 indexed citations
6.
Yang, Pinghua, Jianwei Liu, Hui Xue, et al.. (2023). Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE. The Oncologist. 28(8). e633–e644. 6 indexed citations
7.
Liu, Jianwei, Yong Xia, Caixia Lü, et al.. (2023). The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion. The Oncologist. 28(11). e1043–e1051. 12 indexed citations
9.
Wei, Tao, Xu‐Feng Zhang, Jin He, et al.. (2022). Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study. British journal of surgery. 109(7). 610–616. 28 indexed citations
10.
Liu, Zhi-Peng, Zhiyu Chen, Cheng-Wu Zhang, Feng Shen, & Tian Yang. (2022). ASO Author Reflections: Prevalence and Factors Influencing Surgical Textbook Outcomes Among Patients Undergoing Liver Resection for Hepatocellular Carcinoma. Annals of Surgical Oncology. 29(7). 4287–4288.
11.
Tsilimigras, Diamantis I., Anghela Z. Paredes, Alfredo Guglielmi, et al.. (2021). The Systemic Immune-inflammation Index Predicts Prognosis in Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis. HPB. 23. S140–S141. 1 indexed citations
12.
Shen, Feng & Jon D. Morris. (2016). Decoding Neural Responses To Emotion in Television Commercials. Journal of Advertising Research. 56(2). 193–204. 46 indexed citations
14.
Jia, Weidong, Zhiyong Huang, Xiangcheng Li, et al.. (2016). Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study. Oncotarget. 8(10). 17246–17257. 23 indexed citations
15.
Zhang, Han, Tian Yang, Mengchao Wu, & Feng Shen. (2015). Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management. Cancer Letters. 379(2). 198–205. 231 indexed citations
16.
Zhang, Han, Jun Han, Yingbo Zhu, et al.. (2015). Reporting and methodological qualities of published surgical meta-analyses. Journal of Clinical Epidemiology. 70. 4–16. 32 indexed citations
17.
Shen, Feng. (2013). Appeals and Cultural Values in Chinese Television Commercials. International Business Research. 6(4). 1 indexed citations
18.
Smith, Brent & Feng Shen. (2013). We All Think It’s Cheating, but We All Won’t Report It: Insights Into the Ethics of Marketing Students. SHILAP Revista de lepidopterología. 21(1). 4 indexed citations
19.
Zhao, Xianxian, H. J. Yang, Guojian Jiang, et al.. (2013). Simvastatin attenuates radiation-induced tissue damage in mice. Journal of Radiation Research. 55(2). 257–264. 26 indexed citations
20.
Shen, Feng. (2012). Informational/Transformational Appeals in Political Advertising: An Analysis of the Advertising Strategies of 2010 U.S. Gubernatorial Campaigns. Journal of Nonprofit & Public Sector Marketing. 24(1). 43–64. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026